SCHEMBL6366685

SCHEMBL6366685

COc1cc2c(Oc3ccc4[nH]c(C)cc4c3)ncnc2cc1OCCCC1CCNC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDR P35968 10/20 0.49
▸ RET P07949 3/20 0.49
▸ EGFR P00533 3/20 0.49
▸ MET P08581 2/20 0.49
▸ TEK Q02763 2/20 0.49
▸ AURKB Q96GD4 2/20 0.49
▸ PDGFRA P16234 2/20 0.49
▸ FGFR1 P11362 2/20 0.49
▸ FLT1 P17948 2/20 0.49
▸ FLT4 P35916 2/20 0.49
▸ PLK4 O00444 1/20 0.49
▸ GAK O14976 1/20 0.49
▸ EPHB6 O15197 1/20 0.49
▸ RIPK2 O43353 1/20 0.49
▸ ERN1 O75460 1/20 0.49
▸ STK10 O94804 1/20 0.49
▸ MAP4K4 O95819 1/20 0.49
▸ CHEK2 O96017 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ ERBB2 P04626 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4380414 0.91 KDR (0.49) KDRRETEGFRMETTEK
SCHEMBL7847869 0.89 KDM1A (0.43) KDRRETEGFRMETTEK
SCHEMBL7848576 0.88 PDGFRB (0.48) KDRRETEGFRMETTEK
SCHEMBL665297 0.88 RAF1 (0.52) KDRRETEGFRMETTEK
SCHEMBL7847211 0.87 KDR (0.45) KDRRETEGFRMETTEK
SCHEMBL4384168 0.86 KDR (0.51) KDRRETEGFRMETTEK
SCHEMBL41746 0.86 KDR (0.67) KDRRETEGFRMETTEK
SCHEMBL7848071 0.85 KDM1A (0.47) KDRRETEGFRMETTEK
SCHEMBL7837010 0.84 KDM1A (0.44) KDRRETEGFRMETTEK
SCHEMBL664052 0.84 KDM1A (0.54) KDRRETEGFRMETTEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1553097-A1 QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS AND INTERMEDIATES THEREFORE AstraZeneca AB (SE) 2005-07-13 — — EP disclosed
EP-1154774-A1 QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS AstraZeneca AB (SE) 2001-11-21 — — EP disclosed
WO-2000047212-A1 QUINAZOLINE DERIVATIVES AS ANGIOGENESIS INHIBITORS ASTRAZENECA AB (SE) 2000-08-17 — — WO disclosed
Send feedback